The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|9|2246-2257

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.9, 2015-05, pp. : 2246-2257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA damage response and development of targeted cancer treatments

By Gasser Stephan  

Annals of Medicine, Vol. 39, Iss. 6, 2007-01 ,pp. : 457-464

Informa Healthcare

Access to resources Recommend Favorite

CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 3, 2015-01 ,pp. : 771-776

Spandidos Publications

Access to resources Recommend Favorite

Characterization of Leishmania chagasi DNA Topoisomerase II: a Potential Chemotherapeutic Target

By De Sousa Jacira M.A.   Lareau Susan M.   Pearson Richard D.   Carvalho Edgar M.   Mann Barbara J.   Jeronimo Selma M.B.  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 11-12, 2003-12 ,pp. : 826-829

Informa Healthcare

Access to resources Recommend Favorite

The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl‐DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1858-1867

John Wiley & Sons Inc

Access to resources Recommend Favorite

Histone Post-Translational Modifications in DNA Damage Response

By  

Cytogenetic and Genome Research, Vol. 128, Iss. 1-3, 2010-04 ,pp. : 28-36

Karger

Access to resources Recommend Favorite